期刊文献+

HPLC法测定依托泊苷亚微乳中的药物含量 被引量:5

Determination of etoposide in the submicron emulsions by HPLC
下载PDF
导出
摘要 目的:采用高效液相色谱法测定依托泊苷亚微乳中依托泊苷的含量。方法:采用盐破乳,混合溶剂提取药物的方法,实现药物与亚微乳中油脂的分离,用甲醇定容后高效液相色谱法测定亚微乳中依托泊苷的含量。色谱条件:色谱柱:InertsilODS-3柱(250mm×4.6mm,5μm);流动相:乙腈-pH值4.0醋酸盐缓冲液(32∶68);流速:1.0mL.min-1;柱温:30℃;检测波长:285nm。结果:依托泊苷亚微乳中其他物质对依托泊昔的测定无干扰,在0.80~40.0μg.mL-1范围内线性关系良好(r=0.9999),平均回收率为98.9%,重复性和稳定性良好。结论:本法去除了亚微乳中的油脂,保护了色谱柱,适用于依托泊苷亚微乳的长期质量控制。 Objective:To establish an HPLC method for assaying etoposide in the submicron emulsions. Methods:The submicron emulsions were demulsified by anhydrous sodium sulfate and a mixed solvent was used to extract etoposide from the submicron emulsions. The chromatographic separation was performed on inertsil ODS-3 column (250 mm× 4.6 mm, 5μm) at 30℃. The mobile phase consisted of acetonitrile and pH4.0 acetate buffer solution (32:68 ). The flow rate was set at 1.0 mL. min^-1, and detection at 285 nm. Results : The calibration range was from 0.80 to 40.0μ mL6-1. The recovery was 98.9%. Concluslon:The method can be used for assaying etoposide in the submicron emulsions.
出处 《中国新药杂志》 CAS CSCD 北大核心 2007年第17期1390-1392,共3页 Chinese Journal of New Drugs
关键词 依托泊苷 亚微乳 高效液相色谱法 etoposide submicron emulsions high performance liquid chromatography ( HPLC )
  • 相关文献

参考文献5

  • 1JOYCE RM,REGAN M,OTTAWAY J,et al.A phase Ⅰ-Ⅱ study of rituximab,ifosfamide,mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)[J].Ann Oncol,2003,14(1):121-127.
  • 2SLEVIN ML,CLARK PI,JOEL SP,et al.A randomized trial to evaluate the effect schedule on the activity of etoposide in smallcell lung cancer[J].J Clin 0ncol,1989,7(9):1333 -1340.
  • 3MANOUILOV KK,MCGUIRE TR,GORDON BG,et al.Asaay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection[J].J Chromatogr B Biomed Sci Appl,1998,707 (1/2):342-346.
  • 4王彭三,周浩炳,吴荣莲,叶红杨,王清顺,王世亮.HPLC法测定植入用缓释依托泊苷的含量及相关物质[J].中国新药杂志,2003,12(5):355-357. 被引量:2
  • 5孔蓓蓓,王思玲,苏德森,董敬.伊曲康唑静脉注射乳剂的制备及理化性质的考察[J].中国药剂学杂志(网络版),2006,4(1):7-11. 被引量:4

二级参考文献9

  • 1赵爱华.差示分光光度法测定足叶乙甙注射液含量[J].药物分析杂志,1994,14(5):49-50. 被引量:3
  • 2LiLimark E, Pettersson B, Peterson C, et al. High-performance liquid chromatography with fluorometric detection for monitoring of etoposide and its cis-isomer in plasma and leukaemic cells[J]. J Chromatogr, 1995,669 : 311 - 317.
  • 3Henneberry HP, Aherne GW, Marks V. An ELISA for the measurement of VP- 16 (etoposide) in unextracted plasma [ J ]. J Immunol Methods, 1998,107(2) :205 - 209.
  • 4Saita T, Fujiwara K, Kitagawa T, et al. A highly sensitive enzymelinked immunsorbent assay for etoposide using beta-dgalactosidase as a label[J]. Cancer Chemother Pharmaco1,1990,27(2) : 115 - 120.
  • 5Aslihan Akkar,Rainer H. Müller.Intravenous itraconazole emulsions produced by SolEmuls technology[J].European Journal of Pharmaceutics and Biopharmaceutics.2003(1)
  • 6Aslihan Akkar,Pawel Namsolleck,Michael Blaut,Rainer H. Müller.Solubilizing poorly soluble antimy cotic agents by emulsification via a solvenent-free process[J].AAPS PharmSciTech.2004(1)
  • 7R.H Müller,S Schmidt,I Buttle,A Akkar,J Schmitt,S Br?mer.SolEmuls ? —novel technology for the formulation of i.v. emulsions with poorly soluble drugs[J].International Journal of Pharmaceutics.2003(2)
  • 8BENITA S,LEVY M.Submicron emulsions as colloi-dal drug carriers for intravenous administration:com-prehensive physicochemical characterization[].Jour-nal of Pharmaceutical Sciences.1993
  • 9张虹,陈立仁,夏文斌,翟所迪,郭胤仕,余勤,李家仁.非小细胞肺癌患者低剂量口服鬼臼乙叉苷软胶囊药物动力学[J].中国医院药学杂志,1999,19(11):647-649. 被引量:4

共引文献4

同被引文献16

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部